Sling Therapeutics has closed a significant $123 million Series C financing round, directing the capital toward the pivotal late-stage clinical…
Read More
Scholar Rock Secures Landmark FDA Approval for Isemblyd, Ushering in a New Era of Muscle-Targeted Spinal Muscular Atrophy Treatments
The United States Food and Drug Administration has officially granted approval to Scholar Rock for Isemblyd (apitegromab), establishing a monumental…
Read More
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Solstice Oncology has successfully closed a landmark $225 million Series A funding round to accelerate the clinical development of its…
Read More
Bayer Secures FDA Accelerated Approval for Hyrnuo in Frontline HER2-Mutant Non-Small Cell Lung Cancer
Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…
Read More
Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline
Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…
Read More
Affinia Therapeutics Secures FDA Orphan Drug Designation for AFTX-201, a Promising Gene Therapy for BAG3-Associated Dilated Cardiomyopathy
Affinia Therapeutics has announced a significant milestone in the development of its investigational gene therapy, AFTX-201, with the US Food…
Read More
GSK Secures US Approval for Jideytro in ROS1-Positive Lung Cancer, Entering Competitive Market
Just days after finalizing a monumental $10.6 billion acquisition of Nuvalent, a move that significantly bolsters its oncology pipeline, GlaxoSmithKline…
Read More
Novo Nordisk Secures European Approval for Oral Wegovy, Bolstering First-Mover Advantage in Obesity Pill Market
Novo Nordisk has solidified its pioneering position in the burgeoning market for oral obesity medications with the European Commission’s marketing…
Read More
MSD Secures Landmark Approval for First Oral PCSK9 Inhibitor, Ushering in New Era for Cholesterol Management and Strategic Diversification
The pharmaceutical landscape has been significantly reshaped with MSD (Merck & Co.) achieving a monumental victory: the US Food and…
Read More
Anixa Biosciences Secures Key Patent for Breast Cancer Vaccine Technology in South Korea, Expanding Global Intellectual Property Portfolio
Anixa Biosciences has achieved a significant milestone in its quest to develop a preventive vaccine for breast cancer, securing a…
Read More
